About
Tao Fu joined Frazier Life Sciences as a Venture Partner in 2022 and serves as President and CEO of Attovia Therapeutics, a Frazier Life Sciences portfolio company. He has more than 25 years of experience in pharmaceuticals and biotech, having previously held senior roles including President & COO and Chief Strategy Officer at Zai Lab, Chief Commercial and Business Officer at Portola Pharmaceuticals, and head of M&A roles at Bristol Myers-Squibb and Johnson & Johnson. He holds an MS in biology from the University of Rochester, an MBA from Vanderbilt University, and undergraduate studies in biology at Tsinghua University, and is a CFA.
Invests in
Biotech
Experience
- Attovia TherapeuticsChief Executive Officercurrent2023 β presentFremont, California, United States
- Frazier Life SciencesVenture Partnercurrent2022 β presentMenlo Park, California, United States
- Zai LabPresident & Chief Operating Officer2018 β 2022San Francisco Bay Area
- Portola PharmaceuticalsExecutive Vice President, Chief Commercial and Business Officer2015 β 2018San Francisco, California
- Bristol Myers SquibbVice President, Business Development, Head of M&A and Alliance Management2014 β 2015princeton, new jersey
- Johnson & JohnsonVice President, Business Development, Head of Mergers and Acquisitions/Pharmaceuticals Group2010 β 2014
- Johnson & JohnsonVice President, Business Development2006 β 2010
- SciosVice President, Business Development2002 β 2006
- McKinsey & CompanyConsultant2001 β 2002
- BDManager, Business Development1997 β 2000
Education
- Vanderbilt University Owen Graduate School of ManagementMBA, Finance1995 β 1997
- University of RochesterMS, Biology1992 β 1995
- Tsinghua UniversityUndergraduate Studies, Biology1989 β 1992
Skills & more
From Tao's professional profile.
Same school
Also attended Vanderbilt University Owen Graduate School of Management32
+ 26 more
Also attended University of Rochester56
+ 50 more
Also attended Tsinghua University124
+ 118 more
Shared employers
Also worked at Portola Pharmaceuticals1
Also worked at Bristol Myers Squibb45
+ 39 more
Also worked at Johnson & Johnson128
+ 122 more
Also worked at McKinsey & Company1,128
+ 1,122 more
Investments
Investor
Per the firm's website.




















.png)











.jpg)







